Background: Disruption of electrolyte, redox and neurochemical homeostasis alongside cellular energy crisis is a hallmark of cerebral ischaemia and reperfusion injury. Purpose: This study investigated the effect of kolaviron (KV) on cortical and striatal cation imbalance, oxidative stress and neurochemical disturbances as well as neurobehavioural deficits in animals subjected to bilateral common carotid artery occlusion (BCCAO)-induced ischaemia/reperfusion injury. Methods: KV was administered at a dose of 100 or 200 mg/kg to male Wistar rats 1 h before a 30 min BCCAO/4 h reperfusion (I/R). This was followed by neurobehavioral assessment and biochemical evaluations of cation levels, oxidative stress indicators, lactate dehydrogenase activity and acetylcholinesterase (AChE) activity in the brain of animals. Conclusion: KV significantly restored altered cortical and striatal Ca2+, Na+, K+ and Mg2+ levels, ameliorated redox imbalance, lactic acidosis and modified AChE activity caused by I/R injury. The favourable neurobehavioural effects of KV correlated with biochemical outcomes. The pharmacological potential of KV in the treatment and management of ischemic stroke and allied pathological conditions via multiple targets (neurotransmitter metabolism, bioenergetic failure and ionic homeostasis) is highlighted by the study.

Keywords:
Cerebral ischaemia, Kolaviron, Cation levels, Redox imbalance, Neurobehavioural effects, Stroke
1.
Li S, Li S, Liu C, Liu C, Zhang Y: Extraction and isolation of potential anti-stroke compounds from flowers of Pueraria lobata guided by in vitro PC12 cell model. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1048: 111–120.
2.
Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ: Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Int J Biol Macromol 2016; 88: 320–332.
3.
Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al: Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 2016; 15: 913–924.
4.
Hachinski V, Azarpazhooh MR: Stroke is a burdensome but preventable brain disorder. Lancet Neurol 2016; 15: 892–893.
5.
Martins AH, Hu J, Xu Z, Mu C, Alvarez P, Ford BD, et al: Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia. Neuroscience 2015; 291: 250–259.
6.
Stary CM, Giffard RG: Advances in astrocyte-targeted approaches for stroke therapy: an emerging role for mitochondria and microRNAs. Neurochem Res 2015; 40: 301–307.
7.
Chehaibi K, Trabelsi I, Mahdouani K, Slimane MN: Correlation of oxidative stress parameters and inflammatory markers in ischemic stroke patients. J Stroke Cerebrovasc Dis 2016; 25: 2585–2593.
8.
Davis SM, Pennypacker KR: Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke. Neurochem Int 2017; 107: 23–32.
9.
Hoque A, Hossain MI, Ameen SS, Ang CS, Williamson N, Ng DCH, et al: A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacol Ther 2016; 160: 159–179.
10.
Lau A, Tymianski M: Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010; 460: 525–542.
11.
Leng T, Shi Y, Xiong ZG, Sun D: Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke? Prog Neurobiol 2014; 0: 189–209.
12.
Nour M, Scalzo F, Liebeskind DS: Ischemia-reperfusion injury in stroke. Interv Neurol 2013; 1: 185–199.
13.
Zhang H, Lai Q, Li Y, Liu Y, Yang M: Learning and memory improvement and neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats. J Ethnopharmacol 2017; 196: 225–235.
14.
Guo C, Yin Y, Duan J, Zhu Y, Yan J, Wei G, et al: Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3, 4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae = Danshen] against cerebral ischemia and reperfusion injury in rats. Phytomedicine 2015; 22: 283–289.
15.
Wan L, Cheng Y, Luo Z, Guo H, Zhao W, Gu Q, et al: Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia. J Ethnopharmacol 2015; 165: 118–126.
16.
Kumar GP, Khanum F: Neuroprotective potential of phytochemicals. Pharmacogn Rev 2012; 6: 81–90.
17.
Ishola IO, Adamson FM, Adeyemi OO: Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system. Metab Brain Dis 2017; 32: 235–245.
18.
Kalu WO, Okafor PN, Ijeh II, Eleazu C: Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats. Biomed Pharmacother 2016; 83: 1436-1443.
19.
Milatovic D, Zaja-Milatovic S, Gupta RC: Chapter 29 – Oxidative Stress and Excitotoxicity: Antioxidants from Nutraceuticals: Nutraceuticals. Boston, Academic Press, 2016, pp 401–413.
20.
Suganthy N, Devi KP, Nabavi SF, Braidy N, Nabavi SM: Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions. Biomed Pharmacother 2016; 84: 892–908.
21.
Sunil AG, Kesavanarayanan KS, Kalaivani P, Sathiya S, Ranju V, Priya RJ, et al: Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic-reperfusion injury in rats. Brain Res Bull 2011; 84: 394–405.
22.
Ishige K, Schubert D, Sagara Y: Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 2001; 30: 433–446.
23.
Ijomone OM, Obi AU: Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of wistar rats. Ann Neurosci 2013; 20: 42–46.
24.
Igado OO, Olopade JO, Adesida A, Aina OO, Farombi EO: Morphological and biochemical investigation into the possible neuroprotective effects of kolaviron (Garcinia kola bioflavonoid) on the brains of rats exposed to vanadium. Drug Chem Toxicol 2012; 35: 371–380.
25.
Akinmoladun AC, Akinrinola BL, Olaleye MT, Farombi EO: Kolaviron, a garcinia kola biflavonoid complex, protects against ischemia/reperfusion injury: pertinent mechanistic insights from biochemical and physical evaluations in rat brain. Neurochem Res 2015; 40: 777–787.
26.
Farbiszewski R, Bielawski K, Bielawska A, Sobaniec W: Spermine protects in vivo the antioxidant enzymes in transiently hypoperfused rat brain. Acta Neurobiol Exp (Warsz) 1995; 55: 253–258.
27.
Alexis NE, Dietrich WD, Green EJ, Prado R, Watson BD: Nonocclusive common carotid artery thrombosis in the rat results in reversible sensorimotor and cognitive behavioral deficits. Stroke 1995; 26: 2338–2346.
28.
Beutler E, Duron O, Kelly BM: Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882–888.
29.
Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358.
30.
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588–590.
31.
Misra HP, Fridovich I: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170–3175.
32.
Sinha AK: Colorimetric assay of catalase. Anal Biochem 1972; 47: 389–394.
33.
Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 1996; 239: 70–76.
34.
Ellman GL, Courtney KD, Andres V, Feather-Stone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95.
35.
Wang W, Liu L, Jiang P, Chen C, Zhang T: Levodopa improves learning and memory ability on global cerebral ischemia-reperfusion injured rats in the Morris water maze test. Neurosci Lett 2017; 636: 233–240.
36.
Pei B, Yang M, Qi X, Shen X, Chen X, Zhang F: Quercetin ameliorates ischemia/reperfusion-induced cognitive deficits by inhibiting ASK1/JNK3/caspase-3 by enhancing the Akt signaling pathway. Biochem Biophys Res Commun 2016; 478: 199–205.
37.
Silva BC, de Miranda AS, Rodrigues FG, Silveira ALM, Resende GH de S, Moraes MFD, et al: The 5-lipoxygenase (5-LOX) inhibitor zileuton reduces inflammation and infarct size with improvement in neurological outcome following cerebral ischemia. Curr Neurovasc Res 2015; 12: 398–403.
38.
Schaller B, Graf R: Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 2004; 24: 351–371.
39.
Zeng X, Wang H, Xing X, Wang Q, Li W: Dexmedetomidine protects against transient global cerebral ischemia/reperfusion induced oxidative stress and inflammation in diabetic rats. PloS One 2016; 11:e0151620.
40.
Mansoorali KP, Prakash T, Kotresha D, Prabhu K, Rama Rao N: Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats. Phytomedicine Int J Phytother Phytopharm 2012; 19: 1108–1116.
41.
Allen CL, Bayraktutan U: Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke Off J Int Stroke Soc 2009; 4: 461–470.
42.
Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Hüttemann M: Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 2013; 47: 9–23.
43.
Kvietys PR, Granger DN: Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med 2012; 52: 556–592.
44.
Im JY, Kim D, Paik SG, Han PL: Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic Biol Med 2006; 41: 960–972.
45.
Crack PJ, Taylor JM: Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 2005; 38: 1433–1444.
46.
Kalogeris T, Baines CP, Krenz M, Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012; 298: 229–317.
47.
Webster KA: Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol 2012; 8: 863–884.
48.
Xiong ZG, Xu TL: The role of ASICS in cerebral ischemia. Wiley Interdiscip Rev Membr Transp Signal 2012; 1: 655–662.
49.
Lemasters JJ, Theruvath TP, Zhong Z, Nieminen A-L: Mitochondrial calcium and the permeability transition in cell death. Biochem Biophys Acta 2009; 1787: 1395–1401.
50.
MacDonald JF, Xiong ZG, Jackson MF: Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci 2006; 29: 75–81.
51.
Spencer JP: The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2007; 2: 257–273.
52.
Chinthu R, Anju TR, Paulose CS: Cholinergic receptor alterations in the cerebral cortex of spinal cord injured rat. Biochem Biophys Rep 2017; 10: 46–51.
53.
Báez-Mendoza R, Schultz W: The role of the striatum in social behavior. Front Neurosci 2013; 7: 233.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.